Drug Shortage Report for KETOROLAC TROMETHAMINE INJECTION, USP
| Report ID | 56521 |
| Drug Identification Number | 02443376 |
| Brand name | KETOROLAC TROMETHAMINE INJECTION, USP |
| Common or Proper name | Ketorolac |
| Company Name | MDA INC. |
| Active Ingredient(s) | KETOROLAC TROMETHAMINE |
| Strength(s) | 30MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAMUSCULAR |
| Packaging size | 1 ml Vial |
| ATC code | M01AB |
| ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2018-07-20 |
| Actual start date | 2018-07-25 |
| Estimated end date | 2018-10-29 |
| Actual end date | 2018-10-31 |
| Shortage status | Resolved |
| Updated date | 2018-11-05 |
| Company comments | |
| Health Canada comments | |
| Contact Address | 206-2401 BRISTOL CIRCLE OAKVILLE, ONTARIO CANADA L6H 5S9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.